1 Tizard IR, Jones SW. The Microbiota Regulates Immunity and Immunologic Diseases in Dogs and Cats. Vet Clin North Am Small Anim Pract. 2018;48(2):307-322.
2 Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence?. Vet Med Sci. 2016;2(2):71-94.
3 Hanchi H, Mottawea W, Sebei K, Hammami R. The Genus Enterococcus: Between Probiotic Potential and Safety Concerns-An Update. Front Microbiol. 2018;9:1791.
4 Rose L, Rose J, Gosling S, Holmes M. Efficacy of a Probiotic-Prebiotic Supplement on Incidence of Diarrhea in a Dog Shelter: A Randomized, Double-Blind, Placebo-Controlled Trial. J Vet Intern Med. 2017;31(2):377-382.
5 Bybee SN, Scorza AV, Lappin MR. Effect of the probiotic Enterococcus faecium SF68 on presence of diarrhea in cats and dogs housed in an animal shelter. J Vet Intern Med. 2011;25(4):856-860.
6 Hart ML, Suchodolski JS, Steiner JM, Webb CB. Open-label trial of a multi-strain synbiotic in cats with chronic diarrhea. J Feline Med Surg. 2012;14(4):240-245.
7 Lappin MR. Research and Cinical Experience with Probiotics. In: Proceedings of the Nestlé Purina Companion Animal Nutrition Summit: The Gastrointestinal Tract in Health and Disease. Lisbon, Portugal: Nestlé Purina PetCare, 2012, pp. 46–51.
8 Grześkowiak Ł, Endo A, Beasley S, Salminen S. Microbiota and probiotics in canine and feline welfare. Anaerobe. 2015;34:14-23.
9 Beynen AC. Yeast in petfood. Creature Companion. 2019;12(2):44-45.
10 todaysveterinarypractice.com/probiotics-prebiotics-synbiotics-dogs-cats
11 petmd.com/dog/nutrition/brewers-yeast-dogs-understanding-benefits-and-risks
12 petmd.com/blogs/thedailyvet/ktudor/2012/may/prebiotics_and_weight_loss_in_pets-20540
13 Garcia-Mazcorro JF, Barcenas-Walls JR, Suchodolski JS, Steiner JM. Molecular assessment of the fecal microbiota in healthy cats and dogs before and during supplementation with fructo-oligosaccharides (FOS) and inulin using high-throughput 454-pyrosequencing. PeerJ. 2017;5:e3184.
14 Pinna C, Vecchiato CG, Bolduan C, et al. Influence of dietary protein and fructooligosaccharides on fecal fermentative end-products, fecal bacterial populations and apparent total tract digestibility in dogs. BMC Vet Res. 2018;14(1):106.
15 Félix AP, Brito CB, Zanatta CP, et al. Supplementation of fructooligosaccharides (FOS) on faecal characteristics of adult dogs. Arch Vet Sci. 2012;18(1):9-14.
16 Kanakupt K, Vester Boler BM, Dunsford BR, Fahey GC Jr. Effects of short-chain fructooligosaccharides and galactooligosaccharides, individually and in combination, on nutrient digestibility, fecal fermentative metabolite concentrations, and large bowel microbial ecology of healthy adults cats. J Anim Sci. 2011;89(5):1376-1384.
17 Wernimont SM, Radosevich J, Jackson MI, et al. The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease. Front Microbiol. 2020;11:1266.
18 Tapiero H, Mathé G, Couvreur P, Tew KD. II. Glutamine and glutamate. Biomed Pharmacother. 2002;56(9):446-457.
19 Kelly B, Pearce EL. Amino Assets: How Amino Acids Support Immunity. Cell Metab. 2020;32(2):154-175.
20 Ganor Y, Levite M. Glutamate in the immune system: Glutamate receptors in immune cells, potent effects, endogenous production and involvement in disease. In: Levite M, editor. Nerve-Driven Immunity: Neurotransmitters and Neuropeptides in the Immune System. Vienna, Austria: Springer, 2012, pp. 121–161.
21 Tomé D. The Roles of Dietary Glutamate in the Intestine. Ann Nutr Metab. 2018;73 Suppl 5:15-20.
22 Elliott DA. Nutritional considerations for the gastrointestinal patient. Bull Acad Vét Fr. 2006;159(1):343-348.
23 Yang Z, Liao SF. Physiological Effects of Dietary Amino Acids on Gut Health and Functions of Swine. Front Vet Sci. 2019;6:169.
24 Reeds PJ, Burrin DG, Stoll B, Jahoor F. Intestinal glutamate metabolism. J Nutr. 2000;130(4S Suppl):978S-82S.
25 Wong JY, Abdulla MA, Raman J, et al. Gastroprotective Effects of Lion's Mane Mushroom Hericium erinaceus (Bull.:Fr.) Pers. (Aphyllophoromycetideae) Extract against Ethanol-Induced Ulcer in Rats. Evid Based Complement Alternat Med. 2013;2013:492976.
26 Diling C, Xin Y, Chaoqun Z, et al. Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota. Oncotarget. 2017;8(49):85838-85857.
27 Ren Y, Geng Y, Du Y, et al. Polysaccharide of Hericium erinaceus attenuates colitis in C57BL/6 mice via regulation of oxidative stress, inflammation-related signaling pathways and modulating the composition of the gut microbiota. J Nutr Biochem. 2018;57:67-76.
28 Wang XY, Yin JY, Nie SP, Xie MY. Isolation, purification and physicochemical properties of polysaccharide from fruiting body of Hericium erinaceus and its effect on colonic health of mice. Int J Biol Macromol. 2018;107(Pt A):1310-1319.
29 Wang XY, Yin JY, Zhao MM, Liu SY, Nie SP, Xie MY. Gastroprotective activity of polysaccharide from Hericium erinaceus against ethanol-induced gastric mucosal lesion and pylorus ligation-induced gastric ulcer, and its antioxidant activities. Carbohydr Polym. 2018;186:100-109.
30 Wu Y, Jiang H, Zhu E, et al. Hericium erinaceus polysaccharide facilitates restoration of injured intestinal mucosal immunity in Muscovy duck reovirus-infected Muscovy ducklings. Int J Biol Macromol. 2018;107(Pt A):1151-1161.
31 Friedman M. Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. J Agric Food Chem. 2015;63(32):7108-7123.
32 Jiang S, Wang S, Sun Y, Zhang Q. Medicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticals. Appl Microbiol Biotechnol. 2014;98(18):7661-7670.
33 Wynn SG, Fougère BJ. CHAPTER 20 – Veterinary Herbal Medicine: A Systems-Based Approach. In: Veterinary Herbal Medicine. Saint Louis: Mosby, 2007, pp. 291-409.
34 Badgujar SB, Patel VV, Bandivdekar AH. Foeniculum vulgare Mill: a review of its botany, phytochemistry, pharmacology, contemporary application, and toxicology. Biomed Res Int. 2014;2014:842674.
35 Rather MA, Dar BA, Sofi SN, Bhat BA, Qurishi MA. Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety. Arab J Chem. 2016;9(2):S1574-S1583.
36 Gulfraz M, Arshad M, Uzma N, Shabir K. Comparison in Various Bioactive Compounds of Leaves and Seeds of Foeniculum Vulgare Mill. Ethnobot Leafl. 2005;9:6-14.
37 Rahman T, Choudhury MBK. Shiitake Mushroom: A Tool of Medicine. Bangladesh J Med Biochem. 2012;5(1):24-32.
38 Finimundy TC, Dillon AJP, Henriques JAP, Ely MR. A Review on General Nutritional Compounds and Pharmacological Properties of the Lentinula edodes Mushroom. Food Nutr Sci. 2014;5(12):1095-1105.
39 Zhao S, Gao Q, Rong C, et al. Immunomodulatory Effects of Edible and Medicinal Mushrooms and Their Bioactive Immunoregulatory Products. J Fungi (Basel). 2020;6(4):269.
40 Sánchez-Minutti L, López-Valdez F, Rosales-Pérez M, Luna-Suárez S. Effect of heat treatments of Lentinula edodes mushroom on eritadenine concentration. LWT. 2019;102:364-371.
41 Jayachandran M, Xiao J, Xu B. A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota. Int J Mol Sci. 2017;18(9):1934.
42 Miraj S, Alesaeidi S. A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile). Electron Physician. 2016;8(9):3024-3031.
43 Srivastava JK, Shankar E, Gupta S. Chamomile: A herbal medicine of the past with bright future. Mol Med Rep. 2010;3(6):895-901.
44 Russo R, Autore G, Severino L. Pharmaco-toxicological aspects of herbal drugs used in domestic animals. Nat Prod Commun. 2009;4(12):1777-1784.
45 Spiridonov NA. Mechanisms of Action of Herbal Cholagogues. Med Aromat Plants. 2012;1(5):1-4.
46 Sebai H, Jabri MA, Souli A, et al. Antidiarrheal and antioxidant activities of chamomile (Matricaria recutita L.) decoction extract in rats. J Ethnopharmacol. 2014;152(2):327-332.
47 Mehmood MH, Munir S, Khalid UA, Asrar M, Gilani AH. Antidiarrhoeal, antisecretory and antispasmodic activities of Matricaria chamomilla are mediated predominantly through K(+)-channels activation. BMC Complement Altern Med. 2015;15:75.
